EN|中文

Home> > Departments & Centers > Body

Nuclear Medicine

2017-06-23 15:10:21



The department of Nuclear Medicine of West China Hospital is one of the earliest established Nuclear Medicine departments in China and one of the four sites nationwide for granting doctoral degree of nuclear medicine. The department has 24 faculty members, among which there are 8 nuclear medicine physicians (4 professors, 2 associate professors, 2 residents), 2 nuclear physicists, 2 radiochemists, 8 technologists, and 4 nurses. The department of nuclear medicine holds the following renowned titles: the key laboratory of Sichuan province, the key clinical project for the heavy investment and construction of the ministry of health. It has a special, rational designed building of 2,500 square meters and this provides enough space and graceful environment for clinical work, teaching and scientific study. The department also possesses different kinds of advanced equipment worth of more than 50,000,000 Yuan (RMB), such as PET/CT (16 slices), cyclotron, SPECT/CT (6 slices), single-head SPECT, HPLC, spectrophotometer and so on.

 

The department has established laboratories for molecular nuclear medicine, in vitro receptor assay, chemical synthesis, animal distribution experiment and clinical pharmacology of radiopharmaceuticals. The strong and rich substantial and personnel resources have made the department of nuclear medicine a national base for medical, educational and scientific research. In recent years, the department has vigorously developed radionuclide therapy for hyperthyroidism, differentiated thyroid carcinoma and bone metastatic tumor. Through the clinical practices and research of many years, the department has established a series of guidelines for radionuclide therapy. The guidelines are now being popularized and applied nationwide.

 

The scientific research focuses of the department are:

1. Receptor imaging and receptor-mediated radionuclide targeting therapy.

2. Gene imaging and gene transfection-mediated radionuclide targeting therapy.

3. I-131 therapy for thyroid diseases.

4. Radionuclide therapy for bony metastases.

5. Bio-medical imaging and processing.

 

Grants of scientific research:

1. Applicable basic research of insulin carrier in the targeting therapy of hepatoma.          

---National Science Foundation of China

2. I-131 targeting therapy mediated by NIS and TPO transfected tumor cell.              

--- National Science Foundation of China

3. The basic research of radio-labeled tumor necrosis factor for targeting to treat hepatoma and prevent recurrence of hepatoma after surgical operation mediated by asialoglycoprotein receptor.

--- National Science Foundation of China

4. The study on mechanism of differentiation of thyroid cancer induced by retinoic acid and its applicable basic research.

---Foundation of Ministry of Education

5. The clinical application research of radio antisense imaging and treatment mediated by tumor vascular intestinal peptide receptor.

---foundation of Ministry of Health

 

Teaching

    Nuclear Medicine has been the required course for undergraduate students. Student needs to complete 36 periods in a semester.

 

Clinical work

1. Imaging study: averagely, we have around 600 cases of imaging studies per month.

Bone: 250, Thyroid: 250, Kidney: 35, Salivary gland: 25, I-131-WBI: 40

2. Radionuclide therapy

Graves’ hyperthyroidism: 140, differentiated thyroid cancer (DTC): 20, Bone metastases: 10

 

The department of Nuclear Medicine hopes to carry through academic exchange and cooperation with counterparts in the field of basic scientific research, nuclear cardiology, nuclear oncology, and development of radiopharmaceuticals. It is also willing to jointly train postgraduate students in order to increase teaching proficiency and student’s professional competence and exchange visiting scholars.






PreviousNoData

NextNeurosurgery

share :